What are your thoughts on topical roflumilast as becoming standard of care and gradual shifting away from topical corticosteroids?
Featuring Peter Lio, MD |
Clinical Assistant Professor of Dermatology Pediatrics
Northwestern University Feinberg School of Medicine
Chicago, IL